Arthritis drug does not cross placenta in pregnancy, study finds – Medical News Today
Medical News Today |
Arthritis drug does not cross placenta in pregnancy, study finds
Medical News Today The study included 16 pregnant women at ≥30 weeks gestation who were receiving certolizumab pegol at a maintenance dose (200 milligrams every 2 weeks or 400 milligrams every 4 weeks) for any of a range of approved indications, including rheumatoid … |
Powered by WPeMatico
